n-butyl-2-cyanoacrylate

Small moleculeexperimental

Clinical trial activity

7 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
3
Phase 3
2
Phase 4
0

Earliest trial started Jun 1, 2015 (NCT02468180)

Timeline

2010s

  1. Jan 1, 2016

    Earliest Phase 3 Sponsor(trial)

2020s

  1. Jan 1, 2025

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2025

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    Unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • n-butyl-2-cyanoacrylate
  • n-butyl-2-cyanoacrylate

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07230509Phase 2Dec 1, 2025Minia University
NCT07155525Phase 3Sep 15, 2025Minia University
NCT07132541Phase 1Aug 25, 2025Minia University
NCT03388125Phase 3Jan 1, 2016Tanta University
NCT02468167N/AJun 1, 2015Sichuan University
NCT02468206N/AJun 1, 2015Sichuan University
NCT02468180N/AJun 1, 2015Sichuan University
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Minia UniversityAcademic/Hospital3332025
Sichuan UniversityAcademic/Hospital3312015
Tanta UniversityAcademic/Hospital1112016
3 organizations
Page 1 / 1